Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Applications
- Acoustic Bioprinter for Bridging from Bench to Bedside
- Acoustic Bioprinter for In Vitro Vascularization Controlled by Local Cell Density Enhancemen
- Affilin - Precision Targeting Technology for Protein Drug Conjugates
- Affilin - Precision Targeting Technology for Radio Conjugates
- Affilin - Precision Targeting Technology for Cellular Therapies
- Affilin - Precision Targeting Technology for Multispecific Ligands
Biotherapeutics Equipment Supplied In Europe
25 equipment items found
Premium
Manufactured by:AB Sciex LLC based inFramingham, MASSACHUSETTS (USA)
Perform consistent and compliant biotherapeutics characterization faster than ever. With the PA 800 Plus system, you can confidently safeguard the success of your biologics. Run multiple characterizations from a single system that biopharma labs depend on, and produce qualitative and quantitative analyses, with speed and ...
Manufactured by:MV BioTherapeutics SA based inBellinzona, SWITZERLAND
The ApyraMed technology exploits a recombinant live biotherapeutic that promotes adaptive intestinal homeostasis. In cancer patients, it enhances immune system competence, whereas in dysbiosis safeguards the intestinal ...
Manufactured by:Destiny Pharma plc based inBrighton, UNITED KINGDOM
Background to the NTCD-M3 Clostridioides difficile Programme. NTCD-M3 was developed by GI infection physician, Professor Dale Gerding, who is a world-leading specialist in C. difficile, with more than 400 peer-reviewed journal publications, book chapters and review articles in the area. NTCD-M3 has successfully completed Phase 1 and Phase 2b trials with NTCD-M3. The Phase 1 study demonstrated a ...
Manufactured by:Destiny Pharma plc based inBrighton, UNITED KINGDOM
Destiny Pharma is working in collaboration with SporeGen Limited, a UK biotechnology company working exclusively on Bacillus and its applications, to co-develop SporeGen’s SPOR-COV™ product as a novel, preventive treatment for COVID-19. SPOR-COV™ prophylactic approach targets the innate immune system with potential to develop COVID-19 protection within a few days of treatment. ...
Premium
Manufactured by:AB Sciex LLC based inFramingham, MASSACHUSETTS (USA)
Biotransformation studies are necessary for both small and large molecule therapeutics. From fast and efficient metabolic stability and soft spot analysis to in-depth, comprehensive identification of metabolites and catabolites in a sample, SCIEX offers an integrated solution to give you confident answers ...
Manufactured by:Thermo Fisher Scientific based inWaltham, MASSACHUSETTS (USA)
MAM has been broadly embraced by the biotherapeutic industry and regulatory leaders in recent years. Major biopharmaceutical companies are making significant investments to establish a MAM workflow to future proof the development and manufacturing of their biotherapeutics. Historically, the implementation of MAM has not been easy or fast due to the absence of a ...
Manufactured by:Microviable Therapeutics SL based inGijón, SPAIN
Microviable Therapeutics is developing novel technologies and next generation biotherapeutic products by harnessing the treasure of the human microbiota generating innovative solutions that enable to address unmet challenges in human ...
Manufactured by:Navigo Proteins GmbH based inHalle, GERMANY
Navigo Proteins’ Affilin® platform benefits from the inherent engineerability, stability, safety, and ease of manufacturability. Our Precision Targeting unit comprises a versatile toolbox to custom-build selective biotherapeutic drug candidates, tailored in a flexible, modular fashion, to combine optimized selectivity, effector functions, and adjustable serum half-life. ...
Manufactured by:mimiX Biotherapeutics based inBiel/Bienne, SWITZERLAND
Create biological architectures with sound. Sound Induced Morphogenesis (SIM) is a gentle, fast, and easy method to generate multi-cellular, spatially orchestrated tissue constructs using sound waves. This versatile method addresses necessities in the broad field of life sciences, finding application in tissue engineering, regenerative medicine, or pharmaceutical research for drug ...
Manufactured by:Takeda Pharmaceutical Company Limited based inChuo-ku, JAPAN
Adaptate Biotherapeutics is focussed on therapeutic antibodies which harness the potential of patients’ own gamma delta T cells in situ. Gamma delta T cells play a critical role in immune surveillance, recognising malignant/transformed cells through a pattern of stress markers and exerting potent and selective cytotoxicity. ...
Manufactured by:Gyros Protein Technologies AB based inUppsala, SWEDEN
The Gyrolab xPlore system gives your team the agility to develop immunoassays more quickly and increase data quality with minimal hands-on time. Reliable and precise walkaway automated immunoassays accelerate every phase of biotherapeutic product development. Utilizes proprietary Gyrolab CDs. Generates up to 112 high-quality data points per CD within an hour. Samples are ...
Manufactured by:mimiX Biotherapeutics based inBiel/Bienne, SWITZERLAND
Biologicals – Cells, spheroids, organoids- or non-biological particles are dispersed in a hydrogel precursor and loaded in the SIM carrier. A vertical vibration generated with sound is applied, and a pattern is generated within seconds. Crosslinking of the patterned particulates within the hydrogel is carried out by using different stimuli (light, enzymatic, thermal crosslinking) ...
Manufactured by:mimiX Biotherapeutics based inBiel/Bienne, SWITZERLAND
ZAVA is a chemically defined, synthetic hydrogel that allows you to exploit the full potential of SIM – long term patterning, gelation upon demand, and biologically active sites. The hydrogel is photosensitive and crosslinks upon irradiation at 405 nm. MMP-cleavable sites and RGD peptides allow for potential cell spreading and migration and promote cell adhesion. ...
Manufactured by:mimiX Biotherapeutics based inBiel/Bienne, SWITZERLAND
KYTO is a chemically defined, synthetic hydrogel that bears biologically active sites. An MMP-cleavable crosslinker allows for potential cell spreading and migration. The hydrogel can be customised to bear a cell adhesive peptide, RGD, to further fine-tune the properties for specific applications. KYTO increases in viscosity after 8 to 10 minutes, enabling a dense and well-defined cell pattern to ...
Manufactured by:mimiX Biotherapeutics based inBiel/Bienne, SWITZERLAND
LUMPO is a chemically defined, synthetic hydrogel that crosslinks upon irradiation at 405 nm. This hydrogel does not bear any biologically active sites. The viscosity has been optimised to allow for prolonged patterning of single cells or particles. Gelation on demand is ideal to exploit the method of sound induced morphogenesis. ...
Manufactured by:mimiX Biotherapeutics based inBiel/Bienne, SWITZERLAND
BAKU is a chemically defined, synthetic hydrogel based on Dextran and PEG. This hydrogel does not bear any biologically active sites. Viscosity and gelation kinetics were adapted to allow for patterning of individual cells or particles. ...
Manufactured by:Toleris Biotherapeutics GmbH based inWürzburg, GERMANY
AIM Bio has developed a platform of Autoimmunity Modifying Biologicals (AIM Biologicals) that uses soluble, near-physiological proteins to induce selective, antigen-specific immune tolerance. These proteins mimic a natural process observed in pregnancy that protects the embryo from the maternal immune system. By leveraging optimized soluble versions of the non-classical MHC Ib molecule HLA-G, AIM ...
Manufactured by:MV BioTherapeutics SA based inBellinzona, SWITZERLAND
The ApyraVax technology exploits the live attenuated typhoid vaccine as vector to deliver orally an enzyme that breaks down ATP (apyrase) together with desired antigen/s. The innovative feature is the unique ability to generate high-affinity secretory IgA that are protective towards the target infectious ...
Manufactured by:MV BioTherapeutics SA based inBellinzona, SWITZERLAND
SNP-apyrase for oral use in the treatment of IBD • Lead compound, MV010, has shown animal PoC in a murine model of ulcerative colitis. • Abrogation of the pro-inflammatory function of extracellular ATP in the intestine without systemic immune suppression. • Amplification of secretory IgA production in Peyer's patches and gut-associated lymphoid tissue (GALT), ensuring high specificity for ...
Manufactured by:MV BioTherapeutics SA based inBellinzona, SWITZERLAND
MV010/MV004, in cancer immunotherapy • Significant increase of tumor specific cytotoxic T cells infiltrating the tumor microenvironment by combining MV010/MV004 to anti-PD-L1 administration in murine models. • Significantly improved tumor eradication and resistance to subsequent grafting and improved survival in murine models. ...